Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2

Abstract

Background. HCV infection is associated with lipid disorders because this virus utilizes the host lipid metabolism to sustain its life cycle. Several studies have indicated that higher concentrations of serum cholesterol and LDL before treatment are important predictors of higher rates of sustained virological response (SVR). However, most of these studies involved patients infected with HCV genotype 1. Thus, we performed a multi-institutional clinical study to evaluate the impact of lipid profiles on SVR rates in patients with HCV genotype 2. Methods. A total of 100 chronic hepatitis C patients with HCV genotype 2 who received peg-IFN alfa-2b and ribavirin therapy were consecutively enrolled. The significance of age, sex, BMI, AST level, ALT level, WBC, hemoglobin, platelet count, gamma-glutamyltransferase, total cholesterol level (TC), LDL level, HCV RNA, and histological evaluation was examined for SVR using logistic regression analysis. Results. The 100 patients infected with HCV genotype 2 were divided into 2 groups, an SVR group and a non-SVR group. Characteristics of each group were subsequently compared. There was no significant difference in the level of HCV RNA, BMI, platelet, TG, or stage of fibrosis between the groups. However, there were significant differences in the levels of TC and LDL-C. In multivariate logistic regression analysis using baseline characteristics, high TC level was an independent and significant risk factor (relative risk 18.59, P = 0.015) for SVR. Conclusion. Baseline serum total cholesterol levels should be considered when assessing the likelihood of sustained treatment response following the course of peg-IFN and ribavirin therapy in patients with chronic HCV genotype 2 infection.

DOI: 10.1155/2012/317580

Extracted Key Phrases

5 Figures and Tables

Statistics

02004002014201520162017
Citations per Year

106 Citations

Semantic Scholar estimates that this publication has 106 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Taura2012BaselineSC, title={Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2}, author={Naota Taura and Tatsuki Ichikawa and Hisamitsu Miyaaki and Yoshiko Kadokawa and Takuya Tsutsumi and Shotaro Tsuruta and Yuji Kato and Osami Inoue and Noboru Kinoshita and Kazuo Ohba and Hiroyuki Kato and Kazuyuki Ohata and Junichi Masuda and Keisuke Hamasaki and Hiroshi Yatsuhashi and Kazuhiko Nakao}, booktitle={Gastroenterology research and practice}, year={2012} }